Randomized, double-blind, and multicenter phase II trial of rh-endostatin plus dacarbazine versus dacarbazine alone as first-line therapy for the patients with advanced melanoma.
机构:[1]Peking Univ, Canc Hosp & Inst, Beijing 100871, Peoples R China[2]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China[3]Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China[4]Kunming Med Coll, Affiliated Hosp 3, Kunming, Peoples R China[5]Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China临床科室内科中山大学肿瘤防治中心[6]Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China[7]Nanjing Bayi Hosp, Nanjing, Peoples R China
出处:
ISSN:
语种:
外文
WOS:
中科院(CAS)分区:
出版当年[2012]版:
大类|1 区医学
小类|1 区肿瘤学
最新[2023]版:
大类|1 区医学
小类|1 区肿瘤学
第一作者:
第一作者机构:[1]Peking Univ, Canc Hosp & Inst, Beijing 100871, Peoples R China[2]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China[3]Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China[4]Kunming Med Coll, Affiliated Hosp 3, Kunming, Peoples R China[5]Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China[6]Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China[7]Nanjing Bayi Hosp, Nanjing, Peoples R China
推荐引用方式(GB/T 7714):
Guo Jun,Cui Chuan Liang,Gu Kangsheng,et al.Randomized, double-blind, and multicenter phase II trial of rh-endostatin plus dacarbazine versus dacarbazine alone as first-line therapy for the patients with advanced melanoma.[J].JOURNAL OF CLINICAL ONCOLOGY.2012,30(15):-.
APA:
Guo, Jun,Cui, Chuan Liang,Gu, Kangsheng,Tao, Min,Xin, Song...&Qin, Shukui.(2012).Randomized, double-blind, and multicenter phase II trial of rh-endostatin plus dacarbazine versus dacarbazine alone as first-line therapy for the patients with advanced melanoma..JOURNAL OF CLINICAL ONCOLOGY,30,(15)
MLA:
Guo, Jun,et al."Randomized, double-blind, and multicenter phase II trial of rh-endostatin plus dacarbazine versus dacarbazine alone as first-line therapy for the patients with advanced melanoma.".JOURNAL OF CLINICAL ONCOLOGY 30..15(2012):-